COVID numbers quietly beginning to rise again.Looks like the COVID virus is beginning to rear it's ugly head, again, in at least 3 of Canada's provinces. This time it is a subvarient of the Omicron offshoot of COVID. The US is also watching the numbers as well and expects numbers to begin rising, again, as colder weather approaches and people are spending more time indoors. With travel and other restrictions now lifted and the wearing of masks made optional and more and more people now vaccinated, health management agencies are worried that people will not be on guard against the virus but, at least, this time round, hopefully the new varient of Omicron will be less of a problem then previous varients of the COVID-19 virus. It could well be that the FDA wants to see if, as with the Omicron and previous varients of the COVID-19 virus family, THRM's AcuVid test will be able to detect, with a high level of accuracy, this new subvarient of Omicron as it was able to detect the other varients. Perhaps, this is why it is taking a bit longer for the anticipated FDA approval. Remember, that with the previous update on the progress of the approval procedure, that the company indicated that it was still working with the FDA on some additional requests by the agency and would provide additional updates when they were able. The fact that the FDA has been providing feedback, to the company, in regard to the affectiveness of the Acu-Vid test tells me that they are still very interested in the test as a viable option in the detection of the many varients of COVID-19. The test is simple, inexpensive, or, certainly reasonably inexpensive and quickly detects these varients. Once approved, I wouldn't doubt that the US government will be placing a big order, along with other government buyers from a number of nations and the FDA is probably also need assurances that THRM will be able to meet the demand in a timely way. Flu season and COVID season are not too far off so the clock is ticking at the FDA to have a newer and much less invasive test approved and into the hands of pharmacists, hospitals, doctor's offices and other dispensers of home test kits in time. It will happen. We just have to give it time.